The global biosimilars market is poised for substantial growth in the coming years, driven by increasing healthcare costs, the growing prevalence of chronic diseases, and the expiration of patents for major biologic drugs. As the world increasingly shifts toward more affordable biological therapies, biosimilars are emerging as a key solution to meet the demand for high-quality, cost-effective...
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek